12/3
09:00 am
livn
LivaNova to Highlight Real-World Evidence from CORE-VNS Study and New Health Economics Analyses at American Epilepsy Society 2025 Annual Meeting
Low
Report
LivaNova to Highlight Real-World Evidence from CORE-VNS Study and New Health Economics Analyses at American Epilepsy Society 2025 Annual Meeting
12/3
04:51 am
livn
LivaNova Appoints Lucile Blaise as Global Head of Commercialization, Obstructive Sleep Apnea [Yahoo! Finance]
Low
Report
LivaNova Appoints Lucile Blaise as Global Head of Commercialization, Obstructive Sleep Apnea [Yahoo! Finance]
12/2
09:00 am
livn
LivaNova Appoints Lucile Blaise as Global Head of Commercialization, Obstructive Sleep Apnea
Low
Report
LivaNova Appoints Lucile Blaise as Global Head of Commercialization, Obstructive Sleep Apnea
11/28
09:35 pm
livn
A Look at LivaNova's (LIVN) Valuation Following Its Recent 20% Share Price Surge [Yahoo! Finance]
Low
Report
A Look at LivaNova's (LIVN) Valuation Following Its Recent 20% Share Price Surge [Yahoo! Finance]
11/26
02:11 pm
livn
LivaNova (NASDAQ:LIVN) had its "sell (d+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
LivaNova (NASDAQ:LIVN) had its "sell (d+)" rating reaffirmed by analysts at
Weiss Ratings.
11/25
09:43 am
livn
LivaNova to Present at Piper Sandler Healthcare Conference in December [Yahoo! Finance]
Low
Report
LivaNova to Present at Piper Sandler Healthcare Conference in December [Yahoo! Finance]
11/25
09:00 am
livn
LivaNova to Present at Piper Sandler Healthcare Conference in December
Medium
Report
LivaNova to Present at Piper Sandler Healthcare Conference in December
11/24
09:00 am
livn
LivaNova’s VNS Therapy for Drug-Resistant Epilepsy Procedures Receives Increased Provider Reimbursement from U.S. Centers for Medicare & Medicaid Services
Low
Report
LivaNova’s VNS Therapy for Drug-Resistant Epilepsy Procedures Receives Increased Provider Reimbursement from U.S. Centers for Medicare & Medicaid Services
11/13
08:11 am
livn
LivaNova (NASDAQ:LIVN) had its price target raised by analysts at Robert W. Baird from $63.00 to $70.00. They now have an "outperform" rating on the stock.
Low
Report
LivaNova (NASDAQ:LIVN) had its price target raised by analysts at Robert W. Baird from $63.00 to $70.00. They now have an "outperform" rating on the stock.
11/13
08:11 am
livn
LivaNova (NASDAQ:LIVN) had its price target raised by analysts at Mizuho from $65.00 to $70.00. They now have an "outperform" rating on the stock.
Low
Report
LivaNova (NASDAQ:LIVN) had its price target raised by analysts at Mizuho from $65.00 to $70.00. They now have an "outperform" rating on the stock.
11/12
03:53 pm
livn
LivaNova Delivers Strategic Roadmap and Long-Range Financial Plan at Investor Day [Yahoo! Finance]
Low
Report
LivaNova Delivers Strategic Roadmap and Long-Range Financial Plan at Investor Day [Yahoo! Finance]
11/12
03:26 pm
livn
LivaNova Delivers Strategic Roadmap and Long-Range Financial Plan at Investor Day
Low
Report
LivaNova Delivers Strategic Roadmap and Long-Range Financial Plan at Investor Day
11/9
12:43 am
livn
What LivaNova (LIVN)'s Q3 Revenue Growth and China Launch Mean For Shareholders [Yahoo! Finance]
Low
Report
What LivaNova (LIVN)'s Q3 Revenue Growth and China Launch Mean For Shareholders [Yahoo! Finance]
11/6
10:14 pm
livn
LivaNova PLC (LIVN) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Margin Pressures [Yahoo! Finance]
Low
Report
LivaNova PLC (LIVN) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Margin Pressures [Yahoo! Finance]
11/6
12:48 pm
livn
LivaNova (NASDAQ:LIVN) had its price target raised by analysts at Robert W. Baird from $61.00 to $63.00. They now have an "outperform" rating on the stock.
Low
Report
LivaNova (NASDAQ:LIVN) had its price target raised by analysts at Robert W. Baird from $61.00 to $63.00. They now have an "outperform" rating on the stock.
11/5
06:00 am
livn
LivaNova Reports Third-Quarter 2025 Results; Raises 2025 Guidance
Medium
Report
LivaNova Reports Third-Quarter 2025 Results; Raises 2025 Guidance
10/23
09:00 am
livn
LivaNova to Present at Wolfe Research Healthcare Conference in November
Low
Report
LivaNova to Present at Wolfe Research Healthcare Conference in November
10/8
09:00 am
livn
LivaNova to Announce Third-Quarter 2025 Results
Low
Report
LivaNova to Announce Third-Quarter 2025 Results
10/7
09:00 am
livn
LivaNova to Present Scientific Data at International Surgical Sleep Society 2025 Annual Meeting
Low
Report
LivaNova to Present Scientific Data at International Surgical Sleep Society 2025 Annual Meeting
10/6
07:58 am
livn
Assessing LivaNova (LIVN) Valuation After Recent Share Price Swings and Renewed Investor Optimism [Yahoo! Finance]
Low
Report
Assessing LivaNova (LIVN) Valuation After Recent Share Price Swings and Renewed Investor Optimism [Yahoo! Finance]
10/3
03:40 pm
livn
LivaNova (NASDAQ:LIVN) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
LivaNova (NASDAQ:LIVN) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
10/2
07:20 am
livn
LivaNova (NASDAQ:LIVN) was downgraded by analysts at The Goldman Sachs Group, Inc. from a "strong-buy" rating to a "hold" rating.
Medium
Report
LivaNova (NASDAQ:LIVN) was downgraded by analysts at The Goldman Sachs Group, Inc. from a "strong-buy" rating to a "hold" rating.
10/1
07:04 am
livn
LivaNova (NASDAQ:LIVN) was given a new $55.00 price target on by analysts at The Goldman Sachs Group, Inc..
Low
Report
LivaNova (NASDAQ:LIVN) was given a new $55.00 price target on by analysts at The Goldman Sachs Group, Inc..